IRIS
ODDO, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.466
NA - Nord America 2.373
AS - Asia 1.771
SA - Sud America 578
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 9
Totale 8.265
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.305
RU - Federazione Russa 2.096
SG - Singapore 821
IE - Irlanda 496
BR - Brasile 493
CN - Cina 303
HK - Hong Kong 296
SE - Svezia 295
IT - Italia 174
FR - Francia 125
IN - India 87
DE - Germania 80
VN - Vietnam 62
BD - Bangladesh 43
NL - Olanda 38
CA - Canada 36
AR - Argentina 35
GB - Regno Unito 35
FI - Finlandia 26
ZA - Sudafrica 23
AT - Austria 21
JP - Giappone 20
PL - Polonia 20
TR - Turchia 16
PK - Pakistan 15
EC - Ecuador 14
ES - Italia 12
IQ - Iraq 12
MX - Messico 12
UA - Ucraina 11
ID - Indonesia 10
MY - Malesia 10
CO - Colombia 9
EU - Europa 9
MA - Marocco 9
SA - Arabia Saudita 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
CZ - Repubblica Ceca 7
PY - Paraguay 7
TH - Thailandia 7
TN - Tunisia 7
EG - Egitto 6
LT - Lituania 6
PH - Filippine 6
UZ - Uzbekistan 6
CL - Cile 5
KE - Kenya 5
BE - Belgio 4
JO - Giordania 4
KR - Corea 4
PE - Perù 4
TW - Taiwan 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
IL - Israele 3
JM - Giamaica 3
KW - Kuwait 3
KZ - Kazakistan 3
LK - Sri Lanka 3
NI - Nicaragua 3
NP - Nepal 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
CH - Svizzera 1
CR - Costa Rica 1
FJ - Figi 1
GN - Guinea 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
Totale 8.264
Salva come PNG Salva come JPEG
Città #
Moscow 587
Dublin 496
Ashburn 478
Singapore 443
Hong Kong 295
Nyköping 277
Dallas 260
San Jose 244
The Dalles 127
Lauterbourg 88
Los Angeles 87
Chandler 86
Princeton 86
Medford 85
Des Moines 66
Messina 59
Council Bluffs 53
Pune 48
Beijing 41
Buffalo 39
Redondo Beach 39
São Paulo 36
Tianjin 36
Brooklyn 30
Munich 29
Ho Chi Minh City 27
New York 26
Rio de Janeiro 25
Orem 24
Boardman 20
Guangzhou 20
Nuremberg 19
Tokyo 19
Santa Clara 18
Montreal 17
Warsaw 15
Amsterdam 14
Wilmington 14
Frankfurt am Main 13
Johannesburg 13
San Francisco 12
Turku 12
Vienna 12
Chennai 11
Hanoi 11
Phoenix 11
Atlanta 10
Dhaka 10
Shenzhen 10
Belo Horizonte 9
Porto Alegre 9
Rome 9
Stockholm 9
Catania 8
Denver 8
Düsseldorf 8
Guarulhos 8
Jiaxing 8
Shanghai 8
Boston 7
Brno 7
Campinas 7
Chicago 7
Jinan 7
Palermo 7
Toronto 7
Charlotte 6
Goiânia 6
Hyderabad 6
Lappeenranta 6
London 6
Ningbo 6
Baghdad 5
Helsinki 5
Manchester 5
Mumbai 5
Norwalk 5
Poplar 5
Recife 5
Salvador 5
São Bernardo do Campo 5
Tashkent 5
Amman 4
Ankara 4
Araras 4
Augusta 4
Belford Roxo 4
Bexley 4
Cape Town 4
Casablanca 4
Curitiba 4
Istanbul 4
Joinville 4
Lahore 4
Manaus 4
Mexico City 4
Miami 4
Nanjing 4
New Delhi 4
Nova Iguaçu 4
Totale 4.789
Salva come PNG Salva come JPEG
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 333
A Novel Serum-Based Diagnosis of Alzheimer's Disease Using an Advanced Phage-Based Biochip 201
Applications of CRISPR-Cas9 in Alzheimer's Disease and Related Disorders 169
ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD 135
Multipotential Role of Growth Factor Mimetic Peptides for Osteochondral Tissue Engineering 131
Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice 126
The Role of the Transcription Factor Nrf2 in Alzheimer's Disease: Therapeutic Opportunities 121
BACE1 Elevation is Involved in Amyloid Plaque Development in the Triple Transgenic Model of Alzheimer‘s Disease: Differential Aβ Antibody Labeling of Early-Onset Axon Terminal Pathology 121
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer‘s disease 121
Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders 121
Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice 121
An RNAi-Mediated Reduction in Transcription Factor Nrf-2 Blocks the Positive Effects of Dimethyl Fumarate on Metabolic Stress in Alzheimer's Disease 118
Amyloid beta and the longest-lived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease 117
Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Aß oligomers accumulation 116
Aberrant intracellular localization of H3k4me3 demonstrates an early epigenetic phenomenon in Alzheimer's disease 116
Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome 114
Physiologic Response Evaluation of Human Foetal Osteoblast Cells within Engineered 3D-Printed Polylactic Acid Scaffolds 113
Alzheimer's disease: Abeta, tau and synaptic dysfunction 109
Autophagic/lysosomal dysfunction in Alzheimer's disease 106
Generation of a Biotin-Tagged Dual-Display Phage 104
Epigenetic Changes in Alzheimer's Disease: DNA Methylation and Histone Modification 104
Administration of a selective beta 2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease 104
Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits 102
A dynamic relationship between intracellular and extracellular pools of Abeta 100
Amyloid deposits show complexity and intimate spatial relationship with dendrosomatic plasma membranes: an electron microscopic 3D reconstruction analysis in 3xTg-AD mice and aged canine 100
Maternal choline supplementation ameliorates Alzheimer's disease pathology by reducing brain homocysteine levels across multiple generations 100
Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer‘s disease 96
Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology 92
Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation? 87
The ubiquitin-proteasome system in Alzheimer‘s disease 86
Necroptosis activation in Alzheimer's disease 85
Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer‘s disease 83
Generation of a helper phage for the fluorescent detection of peptide-target interactions by dual-display phages 80
Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology 77
beta(2) Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models 75
Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle 74
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology 74
PF-04691502, a PI3K/mTOR Dual Inhibitor, Ameliorates AD-like Pathology in a Mouse Model of AD 73
mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease 73
Genetic suppression of beta 2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies 73
Increased intraneuronal resting [Ca2+] in adult Alzheimer‘s disease mice 72
Silicon‐Based Sensing Surface for Alzheimer's Disease Diagnosis by Phages Probes 72
Innovative Silicon-Based Sensing Strategy for the Alzheimer’s Disease Detection by Phage Display 71
Experience-dependent regulation of vesicular zinc in male and female 3xTg-AD mice 71
Intracellular amyloid-beta in Alzheimer‘s disease 71
Reduced protein turnover mediates functional deficits in transgenic mice expressing the 25 kDa C-terminal fragment of TDP-43 71
Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice 70
Triple-transgenic model of Alzheimer‘s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction 70
Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice 69
Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer‘s disease mice 69
Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits 69
Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles 69
Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer‘s disease 69
Engineered phage-silver nanoparticle complexes as a new tool for targeted therapies 68
Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice 68
The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer's disease 67
Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study 67
M1 receptors play a central role in modulating AD-like pathology in transgenic mice 67
Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease 66
Dyrk1 inhibition improves Alzheimer's disease-like pathology 66
Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice 65
Validation of a 2-day water maze protocol in mice 65
Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer‘s disease 65
Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease 64
Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles 64
Modeling behavioral and neuronal symptoms of Alzheimer‘s disease in mice: a role for intraneuronal amyloid 64
Inhibition of soluble TNF signaling in a mouse model of Alzheimer‘s disease prevents pre-plaque amyloid-associated neuropathology 63
Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer‘s disease progression 63
Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice 63
Congo red and thioflavin-T analogs detect Abeta oligomers 62
Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia 62
Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer‘s disease 62
Genetic Reduction of Mammalian Target of Rapamycin Ameliorates Alzheimer's Disease-Like Cognitive and Pathological Deficits by Restoring Hippocampal Gene Expression Signature 62
Intraneuronal Abeta causes the onset of early Alzheimer‘s disease-related cognitive deficits in transgenic mice 62
Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism 60
The Collagen Chaperone HSP47 Is a New Interactor of APP that Affects the Levels of Extracellular Beta-Amyloid Peptides 59
Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease 59
Identification of learning-induced changes in protein networks in the hippocampi of a mouse model of Alzheimer's disease 59
Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology 58
Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer‘s mouse models 58
Glucocorticoids Exacerbate Cognitive Deficits in TDP-25 Transgenic Mice via a Glutathione-Mediated Mechanism: Implications for Aging, Stress and TDP-43 Proteinopathies 58
Neural stem cells improve memory in an inducible mouse model of neuronal loss 58
The role of nicotinic acetylcholine receptors in Alzheimer‘s disease 57
CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer‘s disease 57
The role of mTOR signaling in Alzheimer disease 57
Genetically altering Abeta distribution from the brain to the vasculature ameliorates tau pathology 56
Oxidative Damage and Amyloid-beta Metabolism in Brain Regions of the Longest-Lived Rodents 56
Sortilin is required for toxic action of Aβ oligomers (AβOs): Extracellular AβOs trigger apoptosis, and intraneuronal AβOs impair degradation pathways 56
Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease 56
Life-long rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and NMDA signaling 56
Peripherally expressed neprilysin reduces brain amyloid burden: A novel approach for treating Alzheimer‘s disease 56
Toxic role of K+ channel oxidation in mammalian brain 55
Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments 54
Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease 54
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story 54
Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer's disease 53
Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice 53
Methylene blue reduces Aβ levels and rescues early cognitive deficit by increasing proteasome activity 52
mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies 51
Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability 51
Totale 8.172
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.190
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022326 9 0 0 1 5 4 41 22 5 0 3 236
2022/20231.021 107 67 48 22 36 100 21 47 544 4 20 5
2023/2024388 5 26 13 103 9 57 0 10 22 22 27 94
2024/20251.695 12 26 29 40 188 32 68 155 537 107 192 309
2025/20264.880 251 271 287 291 385 1.126 716 571 548 271 111 52
Totale 8.402